Vimarsana
Biggest News Aggregation in the World

Peterc Farrell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peterc Farrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peterc Farrell Today - Breaking & Trending Today

Baader Bank Aktiengesellschaft Purchases 25,379 Shares of ResMed Inc. (NYSE:RMD) - Vimarsana News

Baader Bank Aktiengesellschaft Purchases 25,379 Shares of ResMed Inc. (NYSE:RMD)

Baader Bank Aktiengesellschaft raised its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 1,308.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,319 shares of the medical equipment provider’s stock after buying an additional 25,379 shares during the […]

Swiss National Bank Sells 12,700 Shares of ResMed Inc. (NYSE:RMD) - Vimarsana News

Swiss National Bank Sells 12,700 Shares of ResMed Inc. (NYSE:RMD)

Swiss National Bank cut its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 459,900 shares of the medical equipment provider’s stock after selling 12,700 shares during the period. Swiss National Bank owned 0.31% […]

Norden Group LLC Has $241,000 Position in ResMed Inc. (NYSE:RMD) - Vimarsana News

Norden Group LLC Has $241,000 Position in ResMed Inc. (NYSE:RMD)

Norden Group LLC reduced its stake in ResMed Inc. (NYSE:RMD – Free Report) by 19.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,400 shares of the medical equipment provider’s stock after selling 336 shares during the period. Norden Group […]

Royal Bank of Canada Increases ResMed (NYSE:RMD) Price Target to $200.00 - Vimarsana News

Royal Bank of Canada Increases ResMed (NYSE:RMD) Price Target to $200.00

ResMed (NYSE:RMD – Free Report) had its price target raised by Royal Bank of Canada from $187.00 to $200.00 in a report issued on Friday, Benzinga reports. The firm currently has a sector perform rating on the medical equipment provider’s stock. A number of other research analysts have also recently commented on the stock. Oppenheimer […]

Source: wkrb13.com
ResMed (NYSE:RMD) Shares Down 3% After Analyst Downgrade - Vimarsana News

ResMed (NYSE:RMD) Shares Down 3% After Analyst Downgrade

ResMed Inc. (NYSE:RMD – Get Free Report) shares fell 3% during trading on Monday after Oppenheimer lowered their price target on the stock from $205.00 to $200.00. Oppenheimer currently has an outperform rating on the stock. ResMed traded as low as $210.20 and last traded at $211.61. 322,132 shares changed hands during mid-day trading, a […]